Although ADAM10 was up-regulated in the triple-negative breast cancer cell line MDA-MB-231 37, the role of ADAM10 in the regulation of HR-positive breast cancer cells proliferation and migration is still unclear. Here, ADAM10 is linked to triple-negative breast carcinoma.